Riskpilot← Back to searchSign inGet full accessDYBDAL BECK INVEST ApS
APSActiveCVR 36400951Brunemarksvej 17Activities of holding companies · NACE 6421Est. 2014— employeeswww.pharmalogic.dk
Revenue 2024
DKK -35K
+73% vs 2023
EBITDA margin
100.0%
-73% vs 2023
Equity ratio
65.3%
Financial strength
Net profit 2024
DKK 689K
+3217% vs 2023
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
DYBDAL BECK INVEST ApS 
Pharmalogic ApS